Lucid Diagnostics (LUCD) Institutional Ownership $1.25 -0.01 (-0.79%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$1.25 +0.00 (+0.40%) As of 08:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lucid Diagnostics (NASDAQ:LUCD)CurrentInstitutional OwnershipPercentage74.01%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$984.46KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$156.69K Get LUCD Insider Trade Alerts Want to know when executives and insiders are buying or selling Lucid Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LUCD Institutional Buying and Selling by Quarter Lucid Diagnostics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/22/2025 XML Financial LLC178,795$266K0.0%N/A0.197% 2/18/2025 Sunbelt Securities Inc.83,999$67K0.0%N/A0.142% 2/17/2025Luminus Management LLC1,016,720$832K1.0%-11.8%1.713% 2/17/2025Citadel Advisors LLC119,887$98K0.0%N/A0.202% 2/14/2025Nantahala Capital Management LLC94,541$77K0.0%-25.2%0.159% 2/14/2025Lido Advisors LLC140,016$115K0.0%+40.0%0.236% 2/12/2025Geode Capital Management LLC279,504$229K0.0%+30.9%0.471% 2/11/2025LPL Financial LLC53,391$44K0.0%+29.1%0.090% 1/27/2025Sargent Investment Group LLC541,500$442K0.1%N/A0.913% 8/20/2024Nantahala Capital Management LLC126,362$104K0.0%-15.6%0.241% Get the Latest News and Ratings for LUCD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lucid Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 5/20/2024Virtu Financial LLC34,671$28K0.0%+66.4%0.067% 8/14/2023Luminus Management LLC878,378$1.22M0.4%+2.7%2.024% 2/13/2023Levin Capital Strategies L.P.36,799$50K0.0%N/A0.094% 11/15/2022Cantor Fitzgerald L. P.264,653$405K0.0%-20.7%0.698% 11/14/2022Luminus Management LLC846,662$1.30M0.5%-3.1%2.232% 11/14/2022Verition Fund Management LLC36,166$55K0.0%-22.6%0.095% 11/10/2022Nantahala Capital Management LLC286,432$438K0.0%-7.3%0.755% 8/15/2022Nantahala Capital Management LLC308,978$698K0.0%-2.0%0.815% 8/15/2022Luminus Management LLC873,804$1.98M0.6%+15.7%2.304% 7/22/2022Geneos Wealth Management Inc.42,450$98K0.0%-32.0%0.112% 6/2/2022Verition Fund Management LLC36,166$122K0.0%N/A0.095% 5/23/2022Cantor Fitzgerald L. P.333,717$1.12M0.1%-20.0%0.880% 2/15/2022KCL Capital L.P.10,000$54K0.0%N/A0.027% 2/15/2022Covalis Capital LLP134,532$722K0.3%N/A0.365% 2/2/2022New York State Common Retirement Fund13,800$74K0.0%N/A0.037% 2/1/2022Kornitzer Capital Management Inc. KS133,000$714K0.0%N/A0.361% (Data available from 1/1/2016 forward) LUCD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LUCD shares? During the previous two years, 10 institutional investors and hedge funds held shares of Lucid Diagnostics. The most heavily invested institutionals were Luminus Management LLC ($832K), Sargent Investment Group LLC ($442K), XML Financial LLC ($266K), Geode Capital Management LLC ($229K), Lido Advisors LLC ($115K), Citadel Advisors LLC ($98K), and Nantahala Capital Management LLC ($77K).Learn more on LUCD's institutional investors. What percentage of Lucid Diagnostics stock is owned by institutional investors? 74.01% of Lucid Diagnostics stock is owned by institutional investors. Learn more on LUCD's institutional investor holdings. Which institutional investors have been buying Lucid Diagnostics stock? Of the 9 institutional investors that purchased Lucid Diagnostics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sargent Investment Group LLC ($541.50K), XML Financial LLC ($178.80K), Citadel Advisors LLC ($119.89K), Sunbelt Securities Inc. ($84.00K), Geode Capital Management LLC ($65.96K), Lido Advisors LLC ($40K), and Luminus Management LLC ($23.08K). How much institutional buying is happening at Lucid Diagnostics? Institutional investors have bought a total of 1,079,093 shares in the last 24 months. This purchase volume represents approximately $1.02M in transactions. Which Lucid Diagnostics major shareholders have been selling company stock? The following institutional investors have sold Lucid Diagnostics stock in the last 24 months: Luminus Management LLC ($136.20K), and Nantahala Capital Management LLC ($55.16K). How much institutional selling is happening at Lucid Diagnostics? Institutional investors have sold a total of 191,352 shares in the last 24 months. This volume of shares sold represents approximately $156.69K in transactions. Related Companies TMCI Major Shareholders DCTH Major Shareholders NPCE Major Shareholders CLPT Major Shareholders TCMD Major Shareholders SMLR Major Shareholders NNOX Major Shareholders STIM Major Shareholders SMTI Major Shareholders ZIMV Major Shareholders This page (NASDAQ:LUCD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.